Heimdall Insights

Global Mantle Cell Lymphoma Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Mantle Cell Lymphoma Therapeutics Market was valued at $2.6 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.9% CAGR, to an estimated market size of $3.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global Mantle Cell Lymphoma (MCL) Therapeutics market comprises the development, manufacturing, and distribution of pharmaceutical agents used to treat a rare and aggressive subtype of B-cell non-Hodgkin lymphoma. The scope includes targeted therapies such as Bruton Tyrosine Kinase (BTK) inhibitors, monoclonal antibodies, CAR-T cell therapies, and traditional chemo-immunotherapy regimens, while excluding general oncology supportive care not specific to MCL pathology.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Mantle Cell Lymphoma Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • BTK Inhibitors
  • Monoclonal Antibodies
  • Immunotherapy & CAR-T
  • Chemotherapy
  • Other Therapies